Page last updated: 2024-11-02

oxyphenbutazone and Remission, Spontaneous

oxyphenbutazone has been researched along with Remission, Spontaneous in 1 studies

Oxyphenbutazone: A non-steroidal anti-inflammatory drug. Oxyphenbutazone eyedrops have been used abroad in the management of postoperative ocular inflammation, superficial eye injuries, and episcleritis. (From AMA, Drug Evaluations Annual, 1994, p2000) It had been used by mouth in rheumatic disorders such as ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis but such use is no longer considered justified owing to the risk of severe hematological adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p27)
oxyphenbutazone : A metabolite of phenylbutazone obtained by hydroxylation at position 4 of one of the phenyl rings. Commonly used (as its hydrate) to treat pain, swelling and stiffness associated with arthritis and gout, it was withdrawn from the market 1984 following association with blood dyscrasis and Stevens-Johnson syndrome.

Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ehrlich, GE1

Other Studies

1 other study available for oxyphenbutazone and Remission, Spontaneous

ArticleYear
Treatment of rheumatoid arthritis.
    JAMA, 1974, Apr-01, Volume: 228, Issue:1

    Topics: Arthritis, Rheumatoid; Chronic Disease; Gold; Hot Temperature; Humans; Hydrocortisone; Indomethacin;

1974